Effect Of Transdermal Baclofen Iontophoresis With Passive Stretching On Spasticity In Stroke Survivors
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Stroke is an important disability in the world. Stroke survivor s presents
newlinewith complex physical, mental and social issues. Spasticity is a key clinical entity,
newlinewhich has to be addressed. Various pharmacological drugs available in market to
newlinereduce spasticity which are administered through various routes like intrathecal,
newlineoral and intramuscular , but its adverse effects on gastrointestinal system proves
newlinecostly and hampers physiotherapy rehabilitation. Hence different route of drug
newlineadministration like transdermal iontophoresis along with physiotherapy
newlineinterventions can bring a change in spasticity and physiotherapy outcome or not?
newlineObjective
newlineTo determine the effect of transdermal baclofen Iontophoresis with passive
newlinestretching on spasticity and lower limb function in stroke survivors.
newlineStudy Design
newlineSingle blinded randomised controlled trial.
newlineSubjects
newline100 subjects were recruited for this study including both males and
newlinefemales. The subjects were allocated to any of the two groups randomly.
newlineMethods
newlineSubjects with Spastic hemiplegia were divided into two groups. Prior to
newlineintervention spasticity, lower limb function, pain assessed using modified
newlineashworth scale, fugl Meyer assessment and visual analog scale respectively.
newlinevii
newlineExperimental group received transdermal baclofen iontophoresis for 15
newlineminutes four times a week for 4 weeks and 10 repetitions of passive stretching
newlineof calf muscles. The spasticity, lower limb function and pain were re-graded post
newlineintervention after every 4 sessions (every week).The follow up measures were
newlinetaken after 3 months. The Control group received 10 repetitions of passive
newlinestretching.
newlineResults
newlineThe spasticity and pain score were found to be reduced and lower limb
newlinefunction score increased. Spasticity was evaluated using MAS. Pre to post Mas
newlinedifference for experimental group showed to be statistically significant with p
newlinevalue lt 0.0001 on 2nd , 3rd , 4th week and also after 3 months after intervention
newlinewhereas 1st week p value was not significant with p value of 0.762. Lower limb
newlinefunction was assessed by FMA. Pre to post FMA difference for experimental
newlinegroup showed to be statistically significant with p value less than 0.0001 on 2nd ,
newline3rd , 4th week and also after 3 months after intervention whereas 1st week p value
newlinewas not significant with p value of 0.398.Pain score was assessed by VAS. Pre to
newlinepost VAS difference for experimental group showed to be statistically significant
newlinewith p value of less than 0.0001 on 2nd , 3rd , 4th week and also after 3 months
newlineafter intervention whereas 1st week p value was not significant with p value of
newline0.647.
newlineConclusion
newlineThis suggests that transdermal administration with baclofen with physical
newlinetherapy intervention significantly reduced spasticity, improved lower limb function
newlineand reduced pain and which was consistently maintained even after 3 months
newlinefrom the intervention